Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) treatment among cancer patients has been shown to have antiviral effects by reactivating exhausted T cells. However, they could also trigger inflammatory storm. Therefore, prior exposure to ICIs may influence the risk of SARS-CoV2 infection and subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Liu, Shuo, Qin, Yujun, Zhao, Lei, Li, Yiliang, Zhou, Chenghui, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502698/
https://www.ncbi.nlm.nih.gov/pubmed/34688136
http://dx.doi.org/10.1016/j.intimp.2021.108242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502698/
https://www.ncbi.nlm.nih.gov/pubmed/34688136
http://dx.doi.org/10.1016/j.intimp.2021.108242

Ejemplares similares